Abstract In May 2019, the International Scientific Association for Probiotics and Prebiotics
(ISAPP) convened a panel of nutritionists, physiologists and microbiologists to review the …

The gut microbiota has been linked to the emergence of obesity, metabolic syndrome and
the onset of type 2 diabetes through decreased glucose tolerance and insulin resistance …

This update of evidence-based guidelines (GL) aims to translate current evidence and
expert opinion into recommendations for multidisciplinary teams responsible for the optimal …

Non-alcoholic fatty liver disease (NAFLD) is a series of diseases, involving excessive lipid
deposition in the liver and is often accompanied by obesity, diabetes, dyslipidemia …

The human gastrointestinal tract is colonised by a complex ecosystem of microorganisms.
Intestinal bacteria are not only commensal, but they also undergo a synbiotic co-evolution …

NAFLD is currently the main cause of chronic liver disease in developed countries, and the
number of NAFLD patients is growing worldwide. NAFLD often has similar symptoms to …

Treatment for non-alcoholic fatty liver disease (NAFLD) currently consists of lifestyle
modifications such as a low-fat diet, weight loss, and exercise. The gut microbiota forms part …

Gut-liver-brain axis is a three-way highway of information interaction system among the
gastrointestinal tract, liver, and nervous systems. In the past few decades, breakthrough …

Objective To systematically review the effect of oral intake of bacterial probiotics on 15
variables related to obesity, diabetes and non-alcoholic fatty liver disease. Design …

Animal studies indicate that the composition of gut microbiota may be involved in the
progression of insulin resistance to type 2 diabetes. Probiotics and/or prebiotics could be a …